Inhibition of osteo/chondrogenic transformation of vascular smooth muscle cells by MgCl2 via calcium-sensing receptor

Journal of Hypertension

Volumn 35, Issue 3, 2017, Pages 523-532

  Alesutan, Ioana ^a,b,c   Tuffaha, Rashad ^a   Auer, Tilman ^a   Feger, Martina ^a   Pieske, Burkert ^b,c   Lang, Florian ^a   Voelkl, Jakob ^a,b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c DEUTSCHES HERZZENTRUM BERLIN   (Germany)

Author keywords

Calcium sensing receptor; Mg2+; Osteogenic signaling vascular calcification vascular smooth muscle cells

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; CALCIUM SENSING RECEPTOR; COLECALCIFEROL; COLLAGEN TYPE 1; COLLAGEN TYPE 3; FIBRONECTIN; HYDROXYAPATITE; MAGNESIUM CHLORIDE; MESSENGER RNA; PHOSPHATE; TRANSCRIPTION FACTOR MSX2; TRANSCRIPTION FACTOR RUNX2; ALPL PROTEIN, HUMAN; ALPL PROTEIN, MOUSE; BONE DENSITY CONSERVATION AGENT; COL3A1 PROTEIN, MOUSE; COLLAGEN TYPE I, ALPHA 1 CHAIN; HOMEODOMAIN PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTIC SMOOTH MUSCLE CELL; ARTICLE; BLOOD VESSEL CALCIFICATION; BONE DEVELOPMENT; CELL TRANSFORMATION; CHONDROGENESIS; CONTROLLED STUDY; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RNA INTERFERENCE; VASCULAR SMOOTH MUSCLE CELL; ANIMAL; AORTA; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; GENETICS; METABOLISM; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CELL; UPREGULATION; VASCULAR SMOOTH MUSCLE;

ALKALINE PHOSPHATASE; ANIMALS; AORTA; BONE DENSITY CONSERVATION AGENTS; CALCIUM; CELLS, CULTURED; CHOLECALCIFEROL; CHONDROGENESIS; COLLAGEN TYPE I; COLLAGEN TYPE III; CORE BINDING FACTOR ALPHA 1 SUBUNIT; DURAPATITE; FIBRONECTINS; GENE SILENCING; HOMEODOMAIN PROTEINS; HUMANS; MAGNESIUM CHLORIDE; MICE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; OSTEOGENESIS; PHOSPHATES; RECEPTORS, CALCIUM-SENSING; RNA, MESSENGER; SIGNAL TRANSDUCTION; UP-REGULATION; VASCULAR CALCIFICATION;

EID: 85012257809     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000001202     Document Type: Article

References (57)

1. Shanahan CM, Crouthamel MH, Kapustin A, Giachelli CM. Arterial calcification in chronic kidney disease: key roles for calcium and phosphate. Circ Res 2011; 109:697-711.
2. Rattazzi M, Bertacco E, Puato M, Faggin E, Pauletto P. Hypertension and vascular calcification: a vicious cycle? J Hypertens 2012; 30:1885-1893.
3. Shemesh J, Motro M, Grossman C, Morag-Koren N, Apter S, Grossman E. Progression of coronary artery calcification is associated with longterm cardiovascular events in hypertensive adults. J Hypertens 2013; 31:1886-1892.
4. Mizobuchi M, Towler D, Slatopolsky E. Vascular calcification: the killer of patients with chronic kidney disease. J Am Soc Nephrol 2009; 20:1453-1464.
5. Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 2001; 38:938-942.
6. London GM, Guerin AP, Marchais SJ, Metivier F, Pannier B, Adda H. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 2003; 18:1731-1740.
7. Foley RN, Parfrey PS, Sarnak MJ. Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 1998; 9 (12 Suppl):S16-S23.
8. Steitz SA, Speer MY, Curinga G, Yang HY, Haynes P, Aebersold R, et al. Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers. Circ Res 2001; 89:1147-1154.
9. Kapustin AN, Chatrou ML, Drozdov I, Zheng Y, Davidson SM, Soong D, et al. Vascular smooth muscle cell calcification is mediated by regulated exosome secretion. Circ Res 2015; 116:1312-1323.
10. Lang F, Ritz E, Alesutan I, Voelkl J. Impact of aldosterone on osteoin-ductive signaling and vascular calcification. Nephron Physiol 2014; 128:40-45.
11. Lang F, Ritz E, Voelkl J, Alesutan I. Vascular calcification: is aldosterone a culprit? Nephrol Dial Transplant 2013; 28:1080-1084.
12. Shroff RC, McNair R, Figg N, Skepper JN, Schurgers L, Gupta A, et al. Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis. Circulation 2008; 118:1748-1757.
13. Shao JS, Cheng SL, Pingsterhaus JM, Charlton-Kachigian N, Loewy AP, Towler DA. Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals. J Clin Invest 2005; 115:1210-1220.
14. Speer MY, Li X, Hiremath PG, Giachelli CM. Runx2/Cbfa1, but not loss of myocardin, is required for smooth muscle cell lineage reprogramming toward osteochondrogenesis. J Cell Biochem 2010; 110:935-947.
15. Cui RR, Li SJ, Liu LJ, Yi L, Liang QH, Zhu X, et al. MicroRNA-204 regulates vascular smooth muscle cell calcification in vitro and in vivo. Cardiovasc Res 2012; 96:320-329.
16. Lin ME, Chen T, Leaf EM, Speer MY, Giachelli CM. Runx2 Expression in smooth muscle cells is required for arterial medial calcification in mice. Am J Pathol 2015; 185:1958-1969.
17. Sheen CR, Kuss P, Narisawa S, Yadav MC, Nigro J, Wang W, et al. Pathophysiological role of vascular smooth muscle alkaline phosphatase in medial artery calcification. J Bone Miner Res 2014; 30:824-836.
18. Koleganova N, Piecha G, Ritz E, Schirmacher P, Muller A, Meyer HP, et al. Arterial calcification in patients with chronic kidney disease. Nephrol Dial Transplant 2009; 24:2488-2496.
19. Shroff RC, McNair R, Skepper JN, Figg N, Schurgers LJ, Deanfield J, et al. Chronic mineral dysregulation promotes vascular smooth muscle cell adaptation and extracellular matrix calcification. J Am Soc Nephrol 2010; 21:103-112.
20. Meema HE, Oreopoulos DG, Rapoport A. Serum magnesium level and arterial calcification in end-stage renal disease. Kidney Int 1987; 32:388-394.
21. Joao Matias P, Azevedo A, Laranjinha I, Navarro D, Mendes M, Ferreira C, et al. Lower serum magnesium is associated with cardiovascular risk factors and mortality in haemodialysis patients. Blood Purif 2014; 38:244-252.
22. Tzanakis I, Pras A, Kounali D, Mamali V, Kartsonakis V, Mayopoulou-Symvoulidou D, et al. Mitral annular calcifications in haemodialysis patients: a possible protective role of magnesium. Nephrol Dial Transplant 1997; 12:2036-2037.
23. Turgut F, Kanbay M, Metin MR, Uz E, Akcay A, Covic A. Magnesium supplementation helps to improve carotid intima media thickness in patients on hemodialysis. Int Urol Nephrol 2008; 40:1075-1082.
24. Hruby A, O'Donnell CJ, Jacques PF, Meigs JB, Hoffmann U, McKeown NM. Magnesium intake is inversely associated with coronary artery calcification: the Framingham Heart Study. JACC Cardiovasc Imaging 2014; 7:59-69.
25. Massy ZA, Drueke TB. Magnesium and outcomes in patients with chronic kidney disease: focus on vascular calcification, atherosclerosis and survival. Clin Kidney J 2012; 5 (SUPPL. 1):i52-i61.
26. Louvet L, Buchel J, Steppan S, Passlick-Deetjen J, Massy ZA. Magnesium prevents phosphate-induced calcification in human aortic vascular smooth muscle cells. Nephrol Dial Transplant 2013; 28:869-878.
27. Louvet L, Metzinger L, Buchel J, Steppan S, Massy ZA. Magnesium attenuates phosphate-induced deregulation of a microRNA signature and prevents modulation of Smad1 and osterix during the course of vascular calcification. Biomed Res Int 2016; 2016:7419524.
28. Montes de Oca A, Guerrero F, Martinez-Moreno JM, Madueno JA, Herencia C, Peralta A, et al. Magnesium inhibits Wnt/b-catenin activity and reverses the osteogenic transformation of vascular smooth muscle cells. PLoS One 2014; 9:e89525.
29. Gorgels TG, Waarsing JH, de Wolf A, ten Brink JB, Loves WJ, Bergen AA. Dietary magnesium, not calcium, prevents vascular calcification in a mouse model for pseudoxanthoma elasticum. J Mol Med 2010; 88:467-475.
30. Louvet L, Bazin D, Buchel J, Steppan S, Passlick-Deetjen J, Massy ZA. Characterisation of calcium phosphate crystals on calcified human aortic vascular smooth muscle cells and potential role of magnesium. PLoS One 2015; 10:e0115342.
31. Saidak Z, Brazier M, Kamel S, Mentaverri R. Agonists and allosteric modulators of the calcium-sensing receptor and their therapeutic applications. Mol Pharmacol 2009; 76:1131-1144.
32. Molostvov G, Fletcher S, Bland R, Zehnder D. Extracellular calcium-sensing receptor mediated signalling is involved in human vascular smooth muscle cell proliferation and apoptosis. Cell Physiol Biochem 2008; 22:413-422.
33. Molostvov G, Hiemstra TF, Fletcher S, Bland R, Zehnder D. Arterial expression of the calcium-sensing receptor is maintained by physiological pulsation and protects against calcification. PLoS One 2015; 10:e0138833.
34. Alesutan I, Feger M, Tuffaha R, Castor T, Musculus K, Buehling SS, et al. Augmentation of phosphate-induced osteo-/chondrogenic transformation of vascular smooth muscle cells by homoarginine. Cardiovasc Res 2016; 110:408-418.
35. Cohen H, Sherer Y, Shaish A, Shoenfeld Y, Levkovitz H, Bitzur R, et al. Atherogenesis inhibition induced by magnesium-chloride fortification of drinking water. Biol Trace Elem Res 2002; 90:251-259.
36. Alesutan I, Musculus K, Castor T, Alzoubi K, Voelkl J, Lang F. Inhibition of phosphate-induced vascular smooth muscle cell osteo-/chondro-genic signaling and calcification by bafilomycin A1 and methylamine. Kidney Blood Press Res 2015; 40:490-499.
37. Voelkl J, Alesutan I, Leibrock CB, Quintanilla-Martinez L, Kuhn V, Feger M, et al. Spironolactone ameliorates PIT1-dependent vascular osteoinduction in klotho-hypomorphic mice. J Clin Invest 2013; 123:812-822.
38. Voelkl J, Castor T, Musculus K, Viereck R, Mia S, Feger M, et al. SGK1-sensitive regulation of cyclin-dependent kinase inhibitor 1B (p27) in cardiomyocyte hypertrophy. Cell Physiol Biochem 2015; 37:603-614.
39. Henaut L, Boudot C, Massy ZA, Lopez-Fernandez I, Dupont S, Mary A, et al. Calcimimetics increase CaSR expression and reduce mineralization in vascular smooth muscle cells: mechanisms of action. Cardiovasc Res 2014; 101:256-265.
40. Xu J, Bai Y, Jin J, Zhang J, Zhang S, Cui L, et al. Magnesium modulates the expression levels of calcification-associated factors to inhibit calcification in a time-dependent manner. Exp Ther Med 2015; 9:1028-1034.
41. Proudfoot D, Shanahan CM. Nanocrystals seed calcification in more ways than one. Kidney Int 2011; 79:379-382.
42. Zelt JG, McCabe KM, Svajger B, Barron H, Laverty K, Holden RM, et al. Magnesium modifies the impact of calcitriol treatment on vascular calcification in experimental chronic kidney disease. J Pharmacol Exp Ther 2015; 355:451-462.
43. Rodriguez-Ortiz ME, Canalejo A, Herencia C, Martinez-Moreno JM, Peralta-Ramirez A, Perez-Martinez P, et al. Magnesium modulates parathyroid hormone secretion and upregulates parathyroid receptor expression at moderately low calcium concentration. Nephrol Dial Transplant 2014; 29:282-289.
44. Ikari A, Nakajima K, Kawano K, Suketa Y. Polyvalent cation-sensing mechanism increased Na(+)-independent Mg(2+) transport in renal epithelial cells. Biochem Biophys Res Commun 2001; 287: 671-674.
45. Sumida K, Nakamura M, Ubara Y, Marui Y, Tanaka K, Takaichi K, et al. Cinacalcet upregulates calcium-sensing receptors of parathyroid glands in hemodialysis patients. Am J Nephrol 2013; 37:405-412.
46. Felsenfeld AJ, Levine BS, Rodriguez M. Pathophysiology of calcium, phosphorus, and magnesium dysregulation in chronic kidney disease. Seminars Dial 2015; 28:564-577.
47. Remy C, Kirchhoff P, Hafner P, Busque SM, Mueller MK, Geibel JP, et al. Stimulatory pathways of the Calcium-sensing receptor on acid secretion in freshly isolated human gastric glands. Cell Physiol Biochem 2007; 19:33-42.
48. Ciceri P, Volpi E, Brenna I, Elli F, Borghi E, Brancaccio D, et al. The combination of lanthanum chloride and the calcimimetic calindol delays the progression of vascular smooth muscle cells calcification. Biochem Biophys Res Commun 2012; 418:770-773.
49. Loupy A, Ramakrishnan SK, Wootla B, Chambrey R, de la Faille R, Bourgeois S, et al. PTH-independent regulation of blood calcium concentration by the calcium-sensing receptor. J Clin Invest 2012; 122:3355-3367.
50. Callera GE, He Y, Yogi A, Montezano AC, Paravicini T, Yao G, et al. Regulation of the novel Mg2+ transporter transient receptor potential melastatin 7 (TRPM7) cation channel by bradykinin in vascular smooth muscle cells. J Hypertens 2009; 27:155-166.
51. Hamaguchi Y, Matsubara T, Amano T, Uetani T, Asano H, Iwamoto T, et al. Na(+)-independent Mg(2+) transport sensitive to 2-amino-ethoxydiphenyl borate (2-APB) in vascular smooth muscle cells: involvement of TRPM-like channels. J Cell Mol Med 2008; 12: 962-974.
52. Montezano AC, Zimmerman D, Yusuf H, Burger D, Chignalia AZ, Wadhera V, et al. Vascular smooth muscle cell differentiation to an osteogenic phenotype involves TRPM7 modulation by magnesium. Hypertension 2010; 56:453-462.
53. Molostvov G, James S, Fletcher S, Bennett J, Lehnert H, Bland R, et al. Extracellular calcium-sensing receptor is functionally expressed in human artery. Am J Physiol Renal Physiol 2007; 293:F946-F955.
54. Massy ZA, Drueke TB. Vascular calcification. Curr Opin Nephrol Hypertens 2013; 22:405-412.
55. Nakayama K, Nakao K, Takatori Y, Inoue J, Kojo S, Akagi S, et al. Longterm effect of cinacalcet hydrochloride on abdominal aortic calcification in patients on hemodialysis with secondary hyperparathyroidism. Int J Nephrol Renovasc Dis 2013; 7:25-33.
56. Ma J, Folsom AR, Melnick SL, Eckfeldt JH, Sharrett AR, Nabulsi AA, et al. Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: the ARIC study. Atherosclerosis Risk in Communities Study. J Clin Epidemiol 1995; 48:927-940.
57. Ameer OZ, Boyd R, Butlin M, Avolio AP, Phillips JK. Abnormalities associated with progressive aortic vascular dysfunction in chronic kidney disease. Front Physiol 2015; 6:150.